Your browser doesn't support javascript.
loading
IDO Targeting in Sarcoma: Biological and Clinical Implications.
Nafia, Imane; Toulmonde, Maud; Bortolotto, Doriane; Chaibi, Assia; Bodet, Dominique; Rey, Christophe; Velasco, Valerie; Larmonier, Claire B; Cerf, Loïc; Adam, Julien; Le Loarer, François; Savina, Ariel; Bessede, Alban; Italiano, Antoine.
Afiliación
  • Nafia I; Explicyte Immuno-Oncology, Bordeaux, France.
  • Toulmonde M; Department of Medical Oncology, Institut Bergonié, Bordeaux, France.
  • Bortolotto D; Explicyte Immuno-Oncology, Bordeaux, France.
  • Chaibi A; Explicyte Immuno-Oncology, Bordeaux, France.
  • Bodet D; Explicyte Immuno-Oncology, Bordeaux, France.
  • Rey C; Explicyte Immuno-Oncology, Bordeaux, France.
  • Velasco V; Department of Medical Oncology, Institut Bergonié, Bordeaux, France.
  • Larmonier CB; Department of Medical Oncology, Institut Bergonié, Bordeaux, France.
  • Cerf L; Explicyte Immuno-Oncology, Bordeaux, France.
  • Adam J; Department of Pathology, Gustave Roussy, Villejuif, France.
  • Le Loarer F; Department of Medical Oncology, Institut Bergonié, Bordeaux, France.
  • Savina A; Institut Roche, Paris, France.
  • Bessede A; Explicyte Immuno-Oncology, Bordeaux, France.
  • Italiano A; Department of Medical Oncology, Institut Bergonié, Bordeaux, France.
Front Immunol ; 11: 274, 2020.
Article en En | MEDLINE | ID: mdl-32194552
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Sarcoma / Indolamina-Pirrol 2,3,-Dioxigenasa Idioma: En Revista: Front Immunol Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Sarcoma / Indolamina-Pirrol 2,3,-Dioxigenasa Idioma: En Revista: Front Immunol Año: 2020 Tipo del documento: Article